| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | 0.008 | 0.8 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.008 | 0.8 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.0079 | 0.8 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.0097 | 0.8 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.8 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.0075 | 0.8 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.8 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | -0.0062 | 0.8 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | -0.007 | 0.8 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.9 |